Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain

Clinical and Translational Oncology

Volumn 13, Issue 12, 2011, Pages 862-868

  Grávalos, Cristina ^b   García Alfonso, Pilar ^b   Afonso, Ruth ^b   Arrazubi, Virginia ^b   Arrivi, Antoni ^b   Cámara, Juan Carlos ^b   Capdevila, Jaume ^b   Gómez España, Auxiliadora ^b   Lacasta, Adelaida ^b   Manzano, José Luis ^b   Salgado, Mercedes ^b   Sastre, Javier ^a   Díaz Rubio, Eduardo ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b NONE

Author keywords

Capecitabine; Consensus; Neoadjuvant therapy; Radiotherapy; Rectal cancer

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; THYMIDYLATE SYNTHASE;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CHEMORADIOTHERAPY; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONTINUOUS INFUSION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HAND FOOT SYNDROME; HUMAN; LEUKOPENIA; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE RADIOTHERAPY; PROGNOSIS; RECTUM CANCER; RECTUM SURGERY; SPAIN;

COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; EXPERT TESTIMONY; HUMANS; NEOADJUVANT THERAPY; PRACTICE GUIDELINES AS TOPIC; RECTAL NEOPLASMS;

EID: 84856040084     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0747-1     Document Type: Article

References (68)

1. Ferlay J, Shin HR, Bray F et al (2010) GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France. Available from: http://globocan.iarc.fr
2. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765-781
3. Cabanes A, Perez-Gomez B, Aragones N et al (2009) La situación del cáncer en España, 1975-2006. Madrid. Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid. Available at: http://www.isciii.es/htdocs/pdf/epicancerjunio2009.pdf
4. American Cancer Society (2006) Cancer facts & figures. American Cancer Society, Atlanta [Internet]. Available from: http://www.cancer.org/ downloads/STT/CAFF2006PWSecured.pdf
5. American Joint Committee on Cancer (2010) TNM classifi cation of malignant tumours. Colon and rectum. In: Edge SB, Byrd DR, Compton CC (eds) AJCC cancer staging manual, 7th edn. Springer, New York, pp 143-159
6. Copel L, Sosna J, Kruskal JB et al (2007) CT colonography in 546 patients with incomplete colonoscopy. Radiology 244:471-478 (Pubitemid 47080879)
7. Mainenti PP, Romano M, Imbriaco M et al (2005) Added value of CT colonography after a positive conventional colonoscopy: impact on treatment strategy. Abdom Imaging 30:42-47 (Pubitemid 40169506)
8. Morrin MM, Kruskal JB, Farrell RJ et al (1999) Endoluminal CT colonography after an incomplete endoscopic colonoscopy. AJR Am J Roentgenol 172:913-918 (Pubitemid 29505612)
9. Beets-Tan RG, Beets GL, Vliegen RF et al (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357:497-504 (Pubitemid 32173585)
10. Brown G, Daniels IR (2005) Preoperative staging of rectal cancer: the MERCURY research project. Recent Results Cancer Res 165:58-74
11. Bipat S, Glas AS, Slors FJ et al (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology 232:773-783 (Pubitemid 39100263)
12. Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefi t in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693-701 (Pubitemid 350035641)
13. Bujko K, Michalski W, Kepka L et al (2007) Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: an analysis of outcomes in a randomized trial. Int J Radiat Oncol Biol Phys 67:369-377 (Pubitemid 46127610)
14. Fisher B, Wolmark N, Rockette H et al (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 80:21-29 (Pubitemid 18076565)
15. Kim NK, Baik SH, Seong JS et al (2006) Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specifi c mesorectal excision for fixed locally advanced rectal cancer: impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg 244:1024-1030 (Pubitemid 44808646)
16. Rodel C, Martus P, Papadoupolos T et al (2005) Prognostic signifi cance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23:8688-8696 (Pubitemid 46211512)
17. Kim TH, Chang HJ, Kim DY et al (2010) Pathologic nodal classifi cation is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Oncol Biol Phys 77:1158-1165
18. Braendengen M, Tveit KM, Berglund A et al (2008) Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 26:3687-3694
19. Baxter NN, Garcia-Aguilar J (2007) Organ preservation for rectal cancer. J Clin Oncol 25:1014-1020 (Pubitemid 350002869)
20. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123 (Pubitemid 44394918)
21. Harling H, Bulow S, Kronborg O et al (2004) Survival of rectal cancer patients in Denmark during 1994-99. Colorectal Dis 6:153-157 (Pubitemid 38660633)
22. Harling H, Bulow S, Moller LN, Jorgensen T (2005) Hospital volume and outcome of rectal cancer surgery in Denmark 1994-99. Colorectal Dis 7:90-95 (Pubitemid 40246432)
23. Kapiteijn E, Putter H, van de Velde CJ (2002) Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 89:1142-1149 (Pubitemid 34989221)
24. Martling A, Holm T, Rutqvist LE et al (2005) Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 92:225-229 (Pubitemid 40269339)
25. Quirke P, Steele R, Monson J et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821-828
26. Wibe A, Moller B, Norstein J et al (2002) A national strategic change in treatment policy for rectal cancer: implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 45:857-866 (Pubitemid 34761463)
27. Chamlou R, Parc Y, Simon T et al (2007) Longterm results of intersphincteric resection for low rectal cancer. Ann Surg 246:916-921 (Pubitemid 350179170)
28. Rullier E, Laurent C, Bretagnol F et al (2005) Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg 241:465-469 (Pubitemid 40299723)
29. Cornish JA, Tilney HS, Heriot AG et al (2007) A meta-analysis of quality of life for abdominoperineal excision of rectum versus anterior resection for rectal cancer. Ann Surg Oncol 14:2056-2068 (Pubitemid 46988269)
30. Jayne DG, Guillou PJ, Thorpe H et al (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25:3061-3068 (Pubitemid 47224732)
31. Ng SS, Leung KL, Lee JF et al (2008) Laparoscopic-assisted versus open abdominoperinea resection for low rectal cancer: a prospective randomized trial. Ann Surg Oncol 15:2418-2425
32. Guillou PJ, Quirke P, Thorpe H et al (2005) Shortterm endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomized controlled trial. Lancet 365:1718-1726 (Pubitemid 40719107)
33. Wagman LD (2007) Laparoscopic and open surgery for colorectal cancer: reaching equipoise? J Clin Oncol 25:2996-2998 (Pubitemid 47218043)
34. Brown G, Radcliffe AG, Newcombe RG et al (2003) Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90:355-364 (Pubitemid 36324117)
35. Douglass HO Jr, Moertel CG, Mayer RJ et al (1986) Survival after postoperative combination treatment of rectal cancer. N Engl J Med 315: 1294-1295 (Pubitemid 17049694)
36. Krook JE, Moertel CG, Gunderson LL et al (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715
37. Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
38. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740
39. Gerard JP, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24: 4620-4625 (Pubitemid 46630960)
40. MERCURY Study Group (2006) Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333:779
41. Margalit DN, Mamon HJ, Ancukiewicz M et al (2011) Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older. Int J Radiat Oncol Biol Phys (in press)
42. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215-1223 (Pubitemid 44547018)
43. Aschele C, Pinto C, Cordio S et al (2009) Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial. J Clin Oncol 27[18s]:abstr CRA4008
44. Hofheinz R, Wenz F, Post S et al (2009) Capecitabine (Cape) versus 5-fl uorouracil (5-FU)-based (neo-) adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): safety results of a randomized, phase III trial. J Clin Oncol 27[15s]:abstr 4014
45. Borner MM, Schoffski P, de Wit R et al (2002) Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fl uorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer 38:349-358 (Pubitemid 34121962)
46. Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15:110-115 (Pubitemid 27021524)
47. Topham C, Moore J (1997) Patient preferences for chemotherapy schedules used in the treatment of advanced colorectal cancer: a pilot study. Eur J Cancer Care (Engl) 6:291-294 (Pubitemid 127501316)
48. Twelves C, Gollins S, Grieve R, Samuel L (2006) A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer. Ann Oncol 17:239-245 (Pubitemid 43160112)
49. Sawada N, Ishikawa T, Sekiguchi F et al (1999) X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 5:2948-2953 (Pubitemid 29493974)
50. Kocakova I, Svoboda M, Kubosova K et al (2007) Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma. Neoplasma 54:447-453
51. Bazarbashi S, El-Bassiouni M, Abdelsalam M et al (2008) A modern regimen of pre-operative concurrent chemo-radiation therapy in locally advanced rectal cancer. J Surg Oncol 98:167-174
52. Chan AK, Wong AO, Jenken DA (2010) Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer: is it equivalent to 5-FU infusion plus leucovorin and radiotherapy? Int J Radiat Oncol Biol Phys 76:1413-1419
53. Craven I, Crellin A, Cooper R et al (2007) Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer 97:1333-1337 (Pubitemid 350114791)
54. de Bruin AF, Nuyttens JJ, Ferenschild FT et al (2008) Preoperative chemoradiation with capecitabine in locally advanced rectal cancer. Neth J Med 66:71-76 (Pubitemid 351279449)
55. Dupuis O, Vie B, Lledo G et al (2007) Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR Phase II study. Oncology 73:169-176 (Pubitemid 351630046)
56. Kim JS, Kim JS, Cho MJ et al (2002) Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 54:403-408
57. Korkolis DP, Boskos CS, Plataniotis GD et al (2007) Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer. Anticancer Res 27:541-545 (Pubitemid 46374974)
58. Marsh RW, George TJ, Siddiqui T et al (2010) A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer. Am J Clin Oncol 33:251-256
59. Das P, Lin EH, Bhatia S et al (2006) Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fl uorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 66:1378-1383
60. Kim DY, Jung KH, Kim TH et al (2007) Comparison of 5-fl uorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 67:378-384 (Pubitemid 46108315)
61. Yerushalmi R, Idelevich E, Dror Y et al (2006) Preoperative chemoradiation in rectal cancer: retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil. J Surg Oncol 93:529-533 (Pubitemid 43806987)
62. Gerard JP, Azria D, Gourgou-Bourgade S et al (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28:1638-1644
63. Mohiuddin M, Winter K, Mitchell E et al (2006) Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 24:650-655 (Pubitemid 46630429)
64. Bujko K, Glynne-Jones R, Bujko M (2010) Does adjuvant fluoropyrimidine-based chemotherapy provide a benefi t for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomized trials. Ann Oncol 21:1743-1750
65. Gravalos C, Maurel J, Rivera F et al (2010) SEOM clinical guidelines for the adjuvant treatment of colorectal cancer. Clin Transl Oncol 12: 724-728
66. Glynne-Jones R, Grainger J, Harrison M et al (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? Br J Cancer 94:363-371 (Pubitemid 43237561)
67. Fernández-Martos C, Pericay C, Aparicio J et al (2010) Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi ned, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol 28:859-865
68. Engstrom PF, Arnoletti JP, Benson AB et al (2010) NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer V.2.2010